Over the last 7 days, the Biotech industry has risen 6.4%, driven by gains from Celltrion of 11%. During this same period, the Kainos Medicine underperformed, falling 80%. In the past year, the industry is down 41%. As for the next few years, earnings are expected to grow by 19% per annum.
Has the South Korean Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE |
---|---|---|---|---|
Mon, 04 Jul 2022 | ₩62.3t | ₩10.7t | ₩597.6b | 22.4x |
Wed, 01 Jun 2022 | ₩69.0t | ₩10.6t | ₩680.3b | 27.8x |
Fri, 29 Apr 2022 | ₩71.0t | ₩10.0t | ₩866.3b | 26.7x |
Sun, 27 Mar 2022 | ₩75.8t | ₩9.9t | ₩883.7b | 33.3x |
Tue, 22 Feb 2022 | ₩72.4t | ₩9.4t | ₩783.3b | 34.1x |
Thu, 20 Jan 2022 | ₩79.1t | ₩9.4t | ₩787.4b | 34.4x |
Sat, 18 Dec 2021 | ₩97.7t | ₩9.4t | ₩780.1b | 40.8x |
Mon, 15 Nov 2021 | ₩94.1t | ₩9.2t | ₩986.1b | 32.9x |
Wed, 13 Oct 2021 | ₩94.8t | ₩9.2t | ₩986.0b | 36.2x |
Fri, 10 Sep 2021 | ₩116.5t | ₩9.3t | ₩946.2b | 43.2x |
Sun, 08 Aug 2021 | ₩114.8t | ₩9.3t | ₩909.7b | 52.6x |
Sat, 01 May 2021 | ₩101.2t | ₩9.0t | ₩979.0b | 41.7x |
Tue, 02 Feb 2021 | ₩96.7t | ₩8.2t | ₩501.3b | 49.6x |
Fri, 06 Nov 2020 | ₩80.0t | ₩7.5t | ₩291.2b | 32.5x |
Mon, 10 Aug 2020 | ₩87.9t | ₩6.7t | -₩13,176,736,074.00 | 49.2x |
Sun, 03 May 2020 | ₩57.2t | ₩6.1t | -₩304,564,934,452.00 | 43.6x |
Wed, 05 Feb 2020 | ₩46.7t | ₩5.8t | -₩212,594,028,191.00 | 41.2x |
Sat, 09 Nov 2019 | ₩51.3t | ₩5.5t | ₩44.0b | 37.8x |
Fri, 02 Aug 2019 | ₩49.7t | ₩5.4t | ₩112.2b | 40.4x |
40.4x
How does South Korean Biotech compare with similar industries?
KR Market | -2.64% | |
Healthcare | -2.76% | |
Biotech | -2.12% | |
Biotech | -2.12% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A068270 Celltrion | ₩179.00k | 4.4% +₩1.0t | -31.4% | PE49.3x | |
A115450 HLB TherapeuticsLtd | ₩13.75k | 6.6% +₩26.4b | 17.0% | PS9.1x | |
A086820 Bio SolutionLtd | ₩13.65k | 13.8% +₩13.2b | -56.7% | PS13.2x | |
A365270 Curacle | ₩17.70k | 5.0% +₩11.7b | n/a | PS35.7x | |
A235980 MedPacto | ₩22.95k | 2.2% +₩10.7b | -67.8% | PB8x |